ZA974328B - Formulation comprising microparticles, for inhalation. - Google Patents

Formulation comprising microparticles, for inhalation.

Info

Publication number
ZA974328B
ZA974328B ZA9704328A ZA974328A ZA974328B ZA 974328 B ZA974328 B ZA 974328B ZA 9704328 A ZA9704328 A ZA 9704328A ZA 974328 A ZA974328 A ZA 974328A ZA 974328 B ZA974328 B ZA 974328B
Authority
ZA
South Africa
Prior art keywords
microparticles
inhalation
formulation
Prior art date
Application number
ZA9704328A
Inventor
Cheryl Vanessa Rogerson
Ian Joseph Smith
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Publication of ZA974328B publication Critical patent/ZA974328B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9704328A 1996-05-17 1997-05-19 Formulation comprising microparticles, for inhalation. ZA974328B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9610341.1A GB9610341D0 (en) 1996-05-17 1996-05-17 Formulation for inhalation

Publications (1)

Publication Number Publication Date
ZA974328B true ZA974328B (en) 1998-05-19

Family

ID=10793869

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704328A ZA974328B (en) 1996-05-17 1997-05-19 Formulation comprising microparticles, for inhalation.

Country Status (9)

Country Link
JP (1) JP2000512268A (en)
KR (1) KR20000011020A (en)
AR (1) AR007178A1 (en)
AU (1) AU2783897A (en)
CA (1) CA2253478A1 (en)
GB (1) GB9610341D0 (en)
NO (1) NO985341D0 (en)
WO (1) WO1997044012A1 (en)
ZA (1) ZA974328B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
EP1767195A3 (en) * 1998-08-25 2007-04-04 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
ATE365547T1 (en) * 1998-08-25 2007-07-15 Advanced Inhalation Res Inc SPRAY DRIED PROTEIN FORMULATIONS
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
MXPA04005865A (en) 2001-12-19 2004-09-13 Nektar Therapeutics Pulmonary delivery of aminoglycosides.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
GB9410222D0 (en) * 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments
KR970705979A (en) * 1994-09-29 1997-11-03 디 히스 Spray-dried microparticles as therapeutic vehicles as therapeutic agents

Also Published As

Publication number Publication date
NO985341L (en) 1998-11-16
AU2783897A (en) 1997-12-09
GB9610341D0 (en) 1996-07-24
WO1997044012A1 (en) 1997-11-27
AR007178A1 (en) 1999-10-13
JP2000512268A (en) 2000-09-19
NO985341D0 (en) 1998-11-16
CA2253478A1 (en) 1997-11-27
KR20000011020A (en) 2000-02-25

Similar Documents

Publication Publication Date Title
ZA972685B (en) Medicaments.
ZA987092B (en) Inhalation device.
MXPA00004635A (en) Inhalation device.
ZA982021B (en) Inhalation device.
ZA982019B (en) Inhalation device.
ZA973891B (en) Microparticles.
ZA989061B (en) Medicaments.
ZA979585B (en) Pesticidal methods, compositions and devices.
ZA200107983B (en) New compounds, their preparation and use.
ZA9811848B (en) Vaccine.
ZA991307B (en) Antibodies against human CD40.
MXPA01005543A (en) Controlled release formulation comprising gnrh-ii.
DE59812367D1 (en) 2-arylcyclopentan-1,3-dione
ZA993345B (en) Nefazodone dosage form.
ZA200104280B (en) Pharmaceutical combination preparations.
ZA987057B (en) 2-benzoylcyclohexane-1,3-diones.
DE69723848D1 (en) 3-descladinose-2,3-anhydroerythromycin-derivate
DE59804842D1 (en) Aliphatische, emissionsarme, sinterfähige thermoplastische polyurethanformmassen
ZA987056B (en) 2-benzoylcyclohexane-1,3-diones.
ZA974328B (en) Formulation comprising microparticles, for inhalation.
ZA988B (en) 3-aminocarbonyl-/3-aminothiocarbonyl-substituted 2-benzoylcyclohexane-1,3-diones.
ZA985291B (en) Air treatment system.
ZA994697B (en) Pharmaceutical formulation.
ZA979256B (en) Pesticidal methods, compositions and devices.
ZA972059B (en) Components for inhalation devices.